Synopsis of recent research by authors named "Ana Ricobaraza"
- Ana Ricobaraza's research primarily focuses on gene therapy and its application in neurological disorders, particularly epilepsy and metabolic encephalopathies, with significant studies on Dravet syndrome and citrullinemia.
- Recent findings indicate that preferential expression of SCN1A in GABAergic neurons and viral vector-mediated NaV1.1 expression can improve both survival and the epileptic phenotype in mouse models of Dravet syndrome.
- Additionally, her work on gene therapy for conditions like cerebrotendinous xanthomatosis and the development of high-capacity adenoviral vectors highlights innovative approaches for addressing genetic metabolic disorders and enhancing gene delivery methods.
